Journal
EUROPEAN RESPIRATORY REVIEW
Volume 20, Issue 122, Pages 243-253Publisher
EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/09059180.00006511
Keywords
Prognostic factors; pulmonary hypertension; right ventricle
Categories
Funding
- Actelion Pharmaceuticals Ltd (Allschwil, Switzerland)
Ask authors/readers for more resources
Although changes in the pulmonary vasculature are the primary cause of pulmonary arterial hypertension (PAH), severity of symptoms and survival are strongly associated with right ventricular function, and right heart failure is the main cause of death in patients with PAH. Echocardiography and cardiac magnetic resonance imaging allow noninvasive evaluation of right ventricular function and structure, and a number of indices have been shown to have potential prognostic value in PAH. Given the importance of the right ventricle in PAH, preservation and improvement of its function should be important aspects of therapy; however, there are currently few data specifically related to this aspect of treatment response. Simple, reproducible, noninvasive measures of right ventricular function would help to improve the management of patients with PAH, and to provide tools with which to help establish the optimal therapeutic approach to manage not only the effects of the disease on the pulmonary vasculature, but also to support and improve right ventricular function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available